Indian generic-drug firms involved in recalls
Indian generic-drug makers Sun Pharmaceutical Industries and Ranbaxy Laboratories have recalled batches of treatments in the U.S. following complaints of bottling mix-ups.
Trending on the Topix Network
Sat Mar 08, 2014
Ranbaxy Laboratories recalls some batches of generic Lipitor in latest quality blow
Ranbaxy Lab recalls more than 64,000 bottles of a cholesterol drug in the US after doseage mix-up was detected.
Thu Mar 06, 2014
The Washington Post
Flies in India Factory Threaten U.S. Pipeline of Generics
America's $93 billion pipeline of generic pharmaceuticals often starts in places like Toansa, a village in northern India where a drug-making facility rises up beside mustard fields and manure-flecked ox-cart tracks.
Fri Feb 28, 2014
Tech Mahindra, United Spirits shares gain on NSE Nifty inclusion
Summary Shares of Tech Mahindra and United Spirits today rose as much as 3.6 per cent after their inclusion in the benchmark.
Wed Feb 26, 2014
Ranbaxy Laboratories whistleblower: Downgrade pharma industry till India gets its act together
Dinesh Thakur, former Ranbaxy Laboratories Ltd executive who blew the whistle on manufacturing malpractices at the company, has hinted that an effective approach to enforce quality drug manufacturing and export from India would be to downgrade the domestic pharma industry and prevent it from exporting to US till regulators and companies get their ... (more)
Capitol hearing puts pressure on India to ramp up quality controls
Doctors, lawyers, State Department and World Bank spokesmen met on Wednesday to discuss the state of the Indian pharmaceutical world.
Mon Feb 24, 2014
International Business Times
India's Ranbaxy Falls; Suspends Shipments from 2 Plants
Shares of Ranbaxy Laboratories fell as much as 2.7 percent after the drug maker said on Tuesday it has suspended shipments of pharmaceutical ingredients produced at its Toansa and Dewas plants.
Wed Feb 19, 2014
Ranbaxy Laboratories shares gains after settling with NY Attorney General over collusion
Ranbaxy Laboratories Ltd shares gain 3.4 per cent after the New York Attorney General and the US units of the Indian company and Teva Pharmaceutical Industries settled claims that an agreement between the two drugmakers unlawfully restricted competition.
Mon Feb 10, 2014